Utah Medical Products, Inc. (UTMD)
Nasdaq · Healthcare · Medical Instruments & Supplies
$73.31−1.11%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $233M
- P/E (trailing)
- 22.1
- Dividend yield
- 1.7%
- 52-week range
- $53.66 – $76.89
- 52-week change
- +17.26%
- EPS (trailing)
- $3.31
- Next earnings
- Oct 22, 2026
Fiscal year to Dec 2025
- Revenue
- $38.5M (−5.83%)
- Operating margin
- 29.6%
- Diluted EPS
- $3.48
- Free cash flow
- $14.3M
From the company’s annual report on SEC EDGAR.
About Utah Medical Products, Inc.
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices.
Headquarters: Midvale, United States · 140 employees · utahmed.com